Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Oxogluric acid (α-Ketoglutarate) is not approved for any indication in the world but is an investigational drug in the United States. In the United States a phase I clinical trial... Oxogluric acid is sold as a dietary supplement to athletes to improve their performance by helping to remove excess ammonia, but it is not officially approved for this indication and only experimental studies have shown...
- Mechanism
- Curator reviewed
The exact mechanisms of action for α-Ketoglutarate have not yet been elucidated. Some of α-Ketoglutarate’s actions include acting in the Krebs cycle as an intermediate, transamination reactions during the metabolism of amino acids, forming glutamic acid by combining with ammonia, and reducing nitrogen by combining with it as well. Concerning α-Ketoglutarate’s actions with ammonia, it is proposed that α-Ketoglutarate can help patients with propionic academia who have high levels of ammonia and low levels of glutamine/glutamate in their blood. Because endogenous glutamate/glutamine is produced from α-Ketoglutarate, propionic acidemia patients have impaired production of α-Ketoglutarate and supplementation of α-Ketoglutarate should improve the condition of these patients. Several other experimental studies have also shown that administration of α-Ketoglutarate in parenteral nutrition given to post-operative patients helped attenuate the decreased synthesis of muscle protein that is often seen after a surgery. This decreased muscle synthesis is speculated to be due to too low α-Ketoglutarate levels.
- Primary indication
- α-α-Ketoglutarate is not approved for any indication in the world but is an investigational drug in the United States.Curator reviewed
- Formula / weight
- C5H6O5 · 146.0981 g/mol (avg)
- Also known as
- 2-Ketoglutaric acid · 2-oxoglutaric acid · 2-oxopentanedioic acid · Alpha-ketoglutarate · alpha-Ketoglutaric acid
- Code names
- NSC-17391
Resolves to
KPGXRSRHYNQIFN-UHFFFAOYSA-NSMILESOC(=O)CCC(=O)C(O)=OWhat you can answer from here — as of July 16, 2025
Which drugs share a target with Oxogluric acid, and which of those have an active Phase 3 trial?